NCI Company Profile (NASDAQ:NCIT)

NCI, Inc. is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration. The Company helps its clients to navigate the range of cloud, Everything-as-a-Service (EaaS), capacity services and virtualization options available. The Company provides its customers the full lifecycle of cybersecurity services, including policy and planning, compliance, identity and access management, training, education, awareness and enterprise security operations.

What is NCI's stock symbol?

NCI trades on the NASDAQ under the ticker symbol "NCIT."

How were NCI's earnings last quarter?

NCI, Inc. (NASDAQ:NCIT) issued its quarterly earnings data on Wednesday, October, 26th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.23 by $0.01. The firm earned $79.80 million during the quarter, compared to the consensus estimate of $79.28 million. NCI had a return on equity of 10.77% and a net margin of 1.79%. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 EPS. View NCI's Earnings History.

Where is NCI's stock going? Where will NCI's stock price be in 2017?

4 analysts have issued 12 month target prices for NCI's stock. Their forecasts range from $11.00 to $24.00. On average, they anticipate NCI's stock price to reach $18.33 in the next year. View Analyst Ratings for NCI.

What are analysts saying about NCI stock?

Here are some recent quotes from research analysts about NCI stock:

1. According to Zacks Investment Research, "NCI, Inc. is a leading provider of information technology services and solutions to U.S. federal government agencies. NCI's award-winning expertise encompasses areas critical to its customers' mission objectives including enterprise systems management, information assurance, network engineering, and systems development and integration. " (8/15/2017)

3. FBR & Co analysts commented, "We take a neutral perspective on NCI shares for the time being, although we are encouraged by the efforts that the company is taking to position itself for success in an evolving government IT landscape. CEO Paul Dillahay was appointed in October 2016, and we believe he is taking steps to increase NCI’s ability to capture new business. Given that we estimate that this company has a very strong recompete win rate, the base upon which the team can build appears fairly stable. That being said, we think that the company has outsized dependence on a few larger contracts —like the PEO Soldier contract that we estimate accounted for 16% of revenue in 2016—and there may be a near-term sentiment overhang on the stock related to the recently disclosed alleged embezzlement by the former controller. The company does have significant capabilities in agile software development, and we believe management’s approach is inspired; there could be an opportunity to become more constructive in the future, but for the time being, we think that remaining on the sidelines would be advisable." (4/4/2017)

MarketBeat's community ratings are surveys of what our community members think about NCI and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.